GoldBamboo.com - Knowledge is strong medicine
  

Crohn's Disease as related to Infliximab - Blogs


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:





Relate

Crohn's disease; Crohn//'s disease; Inflamatory Bowel Disease; Inflammatory Bowel Disease, Crohn's 

Remicade 



Recent Blog Posts



View Post: Crohn Disease Therapy - Researchers from University of Calgary ...
20 Nov 2009
According to a study from Canada, "Therapy with adalimumab has been shown to be effective in Crohn's disease (CD) patients who have lost response or are intolerant to infliximab. To determine the efficacy of adalimumab in CD patients ...
View Blog: NewsRx Latest News for Professionals - http://www.newsrx.com/



View Post: Crohn's treatment
27 Nov 2009 by Evan  
Infliximab (Remicade). This drug is the first of a group of medications that blocks the body's inflammation response. The US Food and Drug Administration approved the drug for the treatment of moderate to severe Crohn's disease that ...
View Blog: ironminds - http://www.ironminds.com/



View Post: Keeping Crohn's Disease in Check
6 Jun 2009
Researchers divided 508 patients, with moderate to severe Crohn's disease who had not previously been treated with the drugs involved in the study, into three groups. One group received both infliximab and azathioprine, ...
View Blog: Healthnews.com - More Natural Health



View Post: Infliximab (Remicade) cuts need for surgery in ulcerative colitis ...
14 Oct 2009 by pillscribe  
Infliximab or Remicade is a chimeric monoclonal antibody that reduces production of TNF-alpha (tumour necrosis factor alpha) which has been shown to be part of the autoimmune component in Crohn's Disease and rehoumatoid arthritis. ...
View Blog: DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/



View Post: New data confirm the remission of Crohn's disease
29 Oct 2009 by Ceydilek  
Around 69% of patients with Crohn's disease of moderate to severe and high levels of C reactive protein (CRP) and mucosal lesions go into remission with combination therapy of infliximab and azathioprine according to a subanalysis of ...
View Blog: Health Sector Development - http://healthsectordevelopment.blogspot.com/



View Post: CORRECTION: NICE issues preliminary guidance (ACD) on infliximab ...
15 Sep 2009
1.2 Infliximab, within its licensed indications, is recommended as a treatment option for people with severe active Crohn's disease as induction treatment followed by maintenance treatment, only in one or more of the following ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/



View Post: Infliximab, a Drug for Crohn's Disease
11 Oct 2009 by ElhamV495K  
Crohn's Disease (CD) patients undergoing IFX treatment down-regulate the expression levels of the vascular cell adhesion molecule (VCAM-1) and CD40 on the intestinal mucosal endothelium, thus inhibiting T-cell recruitment. ...
View Blog: Inflammablog3 - http://inflammablog3.blogspot.com/



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

GoldBambooTM

Your Integrative Health and Wellness Resource for Crohn's Disease and Infliximab.

November 29, 2009



Page Updated: January 17, 2009
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.